Search results
First-Line Treatment for Lung Cancer
Verywell Health via Yahoo News· 2 years agoWhen you are diagnosed with lung cancer, the preferred initial treatment is called the first-line treatment. It may also be referred to as induction...
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
Zacks via Yahoo Finance· 3 months agoMerck's attempt to use the Keytruda-Lynparza combination in certain non-small cell lung cancer...
Merck's Keytruda gets FDA nod for expanded use in lung cancer
Reuters via Yahoo News· 8 months agoThe U.S. health regulator's approval extends Keytruda's use in combination with chemotherapy as a...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 9 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Merck combination treatment for lung cancer fails late-stage study
Reuters via Yahoo News· 3 months ago(Reuters) - Merck said on Thursday a combination of two of its cancer drugs failed to meet the main...
Novocure Crashes 43% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment
Investor's Business Daily· 1 year agoA medical device from Novocure extended overall survival for lung cancer patients, but NVCR stock...
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer...
Investor's Business Daily· 1 year agoGerman biotechnology company BioNTech said Friday almost a third of patients with a hard-to-treat...
Cancer vaccine being trialled by NHS may herald ‘dawn of a new age’ of treatments
The Independent via Yahoo News· 4 months agoA new mRNA cancer vaccine being trialled in the UK could herald the “dawn of a new age” of...
Merck's lung cancer drug combo fails trial in setback for new therapy class
Reuters via AOL· 6 months agoMerck's experimental anti-TIGIT drug vibostolimab in combination with its approved therapy Keytruda...